Study on innovative pathogenesis and clinical differentiation and treatment of heart failure in coronary heart disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400079759

Enrollment

Unknown

Registered

2024-01-11

Start date

2022-12-01

Completion date

Unknown

Last updated

2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart failure

Interventions

None:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of heart failure; ? Meet the diagnostic criteria of coronary heart disease; ?NYHA II-IV grade; ? Age 18-80; ? Sign the informed consent form.

Exclusion criteria

Exclusion criteria: ? Acute stage of myocardial infarction; ? Severe hepatic insufficiency (ALT>100U/L or AST>100U/L), severe renal insufficiency (glomerular filtration rate 5.5mmol/L); ? Severe hematologic diseases and malignant tumors; ? Pregnancy or lactation period; ? Mental patients; ? Serious heart failure condition, life expectancy within half a year; ? Uncontrolled high blood pressure or diabetes; ? Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
NT-proBNP;Color Doppler echocardiography;	—

Secondary

Measure	Time frame
ST2;hs-CRP;IL-6;NLR;	—

Countries

China

Contacts

Public ContactLijing Zhang

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

dzmyyccu@163.com+86 135 0121 4395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026